• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home One-pagers HepVu Webinar: The Impact of the COVID-19 Pandemic on Viral Hepatitis

HepVu Webinar: The Impact of the COVID-19 Pandemic on Viral Hepatitis

June 2, 2020

On Tuesday, June 2, HepVu convened a webinar to discuss the challenges and potential benefits that COVID-19 presents and bring attention to the systems that need to be put in place for Hepatitis C elimination amid competing health priorities.

To view the recording of the HepVu webinar on “The Impact of the COVID-19 Pandemic on Viral Hepatitis” please see the video below.

Moderator:

  • Ronald Valdiserri, MD, MPH, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services, and Co-Chair of HepVu

Speakers:

  • Alex Billioux, MD, DPhil, Assistant Secretary of Health for the Office of Public Health, Louisiana Department of Health
  • Lauren Canary, MPH, Director, National Viral Hepatitis Roundtable
  • Boatemaa Ntiri-Reid, JD, MPH, Director of Hepatitis, NASTAD

To download the presentation, please click here.

Most Read

Hepatitis C Treatment Restrictions
Combatting Hepatitis C Among People Who Use Drugs in Appalachia
What’s New in Viral Hepatitis – February
Share Facebook Twitter LinkedIn Email

Keep Reading

December 14, 2022

2022: A Year in Review

Read More

December 12, 2022

HepVu Adds 2020 County-Level Opioid Maps and Data

Read More

December 12, 2022

What's New in Viral Hepatitis - December 2022

Read More

November 16, 2022

Suzanne Davies on Managed Care Organizations and Medicaid

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.